Spain Expansion Not Enough: IREN Slide to $27 Highlights Execution Gap

What happened

IREN announced plans for a 300MW AI campus in Spain, lifting its stock 4% on October 21, but the shares still trade at $27, far below the $35.19 level when the master report was written. The expansion adds to IREN's multi-gigawatt ambitions but does not address the near-term questions: only Horizon 1 of four Microsoft tranches has been accepted, and operating ARR remains at $1B versus $4B contracted. The company's FY26 loss of $702.6 million, heavy impairments, and rising SG&A continue to weigh on investor confidence, and the Spain project may further stretch capital allocation. While the news is directionally positive for the AI infrastructure story, it offers no new evidence on customer acceptance timelines or revenue conversion for existing capacity. At $27, the stock now sits below the master report's base case of $36 and closer to the bear case of $24, suggesting the market is pricing in execution risk.

Implication

The stock's decline to $27, below the previously identified attractive entry of $30, may tempt value investors, but the fundamental picture has not improved since the master report. The Spain expansion is consistent with IREN's strategy but adds to capital needs at a time when the company is already burdened with $7.59B debt and negative interest coverage. The key catalysts remain Microsoft acceptance of Horizons 2–4, AI Cloud revenue stepping above $70.5 million per quarter, and disclosure on the flagged $520 million transition impairment. Until those milestones show progress, the WAIT rating from the master report remains appropriate, though the risk/reward is becoming less unfavorable given the lower price. Investors should monitor the next quarterly update; if acceptance and revenue conversion improve, the stock could re-rate toward the base case, but a break below $24 would signal deeper execution problems.

Thesis delta

The stock has fallen from $35.19 to $27, moving below the master report's attractive entry of $30, which marginally improves the risk/reward for long-term investors. However, the Spain campus news does not alter the core thesis: the company still needs to convert contracted ARR into recognized revenue and gain Microsoft acceptance for Horizons 2-4. Thus, the WAIT rating is maintained, with the lower price reducing downside but not yet providing a sufficient margin of safety to turn bullish.